Symbol

ACAD
ANIP
ARIA
ARWR
ATW
BBG
CBM
CLR
CNX
CPE
DO
ECA
EGN
EPE
ETE
FET
FLDM
GEOS
HOS
INO
IO
KERX
KPTI
LNG
LPI
MCF
MRO
MUR
OAS
OIS
OKE
PETX
QEP
RDC
REGI
RICE
RSPP
SCLN
SLCA
SM
SN
SPN
SPPI
SRPT
TDW
TESO
TRGP
TTNP
WLL
WPX

Company Name
ACADIA Pharmaceuticals Inc
ANI Pharmaceuticals Inc
ARIAD Pharmaceuticals Inc
Arrowhead Pharmaceuticals Inc
Atwood Oceanics Inc
Bill Barrett Corp
Cambrex Corp
Continental Resources Inc/OK
CONSOL Energy Inc
Callon Petroleum Co
Diamond Offshore Drilling Inc
Encana Corp Coupon Strip
Energen Corp
EP Energy Corp
Energy Transfer Equity LP
Forum Energy Technologies Inc
Fluidigm Corp
Geospace Technologies Corp
Hornbeck Offshore Services Inc
Inovio Pharmaceuticals Inc
Ion Geophysical Corp
Keryx Biopharmaceuticals Inc
Karyopharm Therapeutics Inc
Cheniere Energy Inc
Laredo Petroleum Inc
Contango Oil & Gas Co
Marathon Oil Corp
Murphy Oil Corp
Oasis Petroleum Inc
Oil States International Inc
ONEOK Inc
Aratana Therapeutics Inc
QEP Resources Inc
Rowan Cos Inc
Renewable Energy Group Inc
Rice Energy Inc
RSP Permian Inc
SciClone Pharmaceuticals Inc
US Silica Holdings Inc
SM Energy Co
Sanchez Energy Corp
Superior Energy Services Inc
Spectrum Pharmaceuticals Inc
Sarepta Therapeutics Inc
Tidewater Inc
TESCO Corp
Targa Resources Corp
Titan Pharmaceuticals Inc
Whiting Petroleum Corp
WPX Energy Inc

Industry Group (GICS)

Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
Energy
Energy
Pharmaceuticals, Biotechnology & Life Sciences
Energy
Energy
Energy
Energy
Energy
Energy
Energy
Energy
Energy
Pharmaceuticals, Biotechnology & Life Sciences
Energy
Energy
Pharmaceuticals, Biotechnology & Life Sciences
Energy
Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
Energy
Energy
Energy
Energy
Energy
Energy
Energy
Energy
Pharmaceuticals, Biotechnology & Life Sciences
Energy
Energy
Energy
Energy
Energy
Pharmaceuticals, Biotechnology & Life Sciences
Energy
Energy
Energy
Energy
Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
Energy
Energy
Energy
Pharmaceuticals, Biotechnology & Life Sciences
Energy
Energy

ZIOP

ZIOPHARM Oncology Inc

Pharmaceuticals, Biotechnology & Life Sciences

Exported as of: 05/09/2016 06:31:30 PM EST

Quotes are delayed at least 15 minutes.
Sector Classifications based on Global Industry Classification Standard ("GICS"). Click here for GICS methodology.
Sector Distribution reflects only domestic common stock holdings.
The security price and market value shown is based on the latest available market data, which is delayed at least 20 minutes.
BofA Merrill Lynch Global Research Volatility Risk Ratings indicators of potential price fluctuation, are:
A - Low
B - Medium
C - High

BofA Merrill Lynch Global Research Investment Ratings reflect the analyst's assessment of a stock's absolute total return pote
1 - Buy (stocks are expected to have a total return of at least 10% and are the most attractive stocks in a Coverage Cluster)
2 - Neutral (stocks are expected to remain flat or increase in value and are less attractive than Buy rated stocks)
3 - Underperform (stocks are the least attractive stocks in a Coverage Cluster).
BofA Merrill Lynch Global Research Income Ratings indicators of potential cash dividends, are:
7 - Same/higher (dividend considered to be secure);
8 - Same/lower (dividend not considered to be secure);
9 - Pays no cash dividend.

Coverage Cluster is comprised of stocks covered by a single analyst or two or more analysts sharing a common industry, secto
The information herein was obtained from multiple sources: we do not guarantee its accuracy or completeness.
The performance data contained herein represents past performance which does not guarantee future results. Investment retu
While we believe our pricing information to be reliable, we cannot guarantee its accuracy.
For Size and Style, security classification is as follows: a capitalization breakpoint of $11.26 billion defines the size (Large Cap
BofA Merrill Lynch Global Research is research produced by Merrill Lynch, Pierce, Fenner & Smith Incorporated ("MLPF&S") a
Please note: None of Bank of America, Merrill Lynch or any affiliates, bears any responsibility or liability with respect to third-pa
To review a description of the third-party ratings methodology click here.
Selected data supplied by Thomson Reuters.
Merrill Edge is available through Merrill Lynch, Pierce, Fenner & Smith Incorporated (MLPF&S), and consists of the Merrill Edg
Investment products:
Are Not FDIC Insured
Are Not Bank Guaranteed
May Lose Value
MLPF&S is a registered broker-dealer, member SIPC and a wholly owned subsidiary of BAC.
Copyright 2012 Bank of America Corporation. All rights reserved.

3 Month Change Last Price Beta

42.82
29.25
51.88
45.42
37.67
7.18
61.56
5.76
64.34
10.12
84.38
6.56
55.82
49.35
100.05
38.74
63.63
13.80
62.70
10.38
31.56
23.20
40.00
5.96
32.42
38.85
75.80
5.84
85.39
12.69
54.24
15.54
41.82
9.13
56.92
15.67
32.45
9.80
49.08
9.52
35.43
7.81
51.27
5.46
36.98
8.26
35.12
32.15
85.40
11.38
98.86
11.93
42.20
11.45
52.92
28.84
54.37
8.68
36.08
31.10
55.72
39.24
64.44
5.52
45.61
16.81
39.47
17.24
34.05
9.09
85.99
17.42
48.11
30.48
48.29
13.29
36.44
23.18
105.52
27.70
184.04
8.47
51.34
14.97
54.43
7.27
44.84
17.63
40.85
7.47
32.50
7.96
75.36
38.83
32.29
5.39
57.45
10.02
79.79
8.21

3.4746
3.3018
1.8656
2.5156
2.4184
3.7113
2.3309
1.4776
1.4142
1.6368
1.0070
3.3756
1.8502
5.0395
1.8231
1.6655
2.9188
1.3799
1.0865
2.9000
4.4151
3.0672
4.3506
1.6032
1.3422
2.3628
2.3715
2.3765
2.3030
1.4536
1.2615
3.7384
1.8551
1.6509
1.3290
1.7589
2.2614
1.8363
2.7319
3.3501
1.4478
2.0518
1.2081
1.2672
1.8608
1.1449
2.3746
1.7983
3.5126
2.3111

Short Interest (%)

17.8613
13.7843
15.9394
19.0399
31.5306
21.2463
9.4473
8.3070
26.1118
14.6564
13.3854
6.4873
9.7141
5.4743
5.7430
12.2741
14.4911
23.6556
28.8416
16.1990
8.1434
18.7924
8.4955
11.2046
13.3700
5.0380
9.3338
12.0475
21.4402
6.7689
7.1786
12.7468
8.6687
17.8753
9.4567
11.5850
11.0907
8.9583
26.6397
28.1649
19.0240
9.6453
13.8401
40.1588
16.5451
8.4894
6.4366
5.1097
25.4963
16.8072

37.25

7.41

2.3914

27.1976

ick here for GICS methodology.

ata, which is delayed at least 20 minutes.

e fluctuation, are:

ment of a stock's absolute total return potential and attractiveness for investment relative to other stocks within its Coverage Cluster (defined
attractive stocks in a Coverage Cluster)
ctive than Buy rated stocks)

analysts sharing a common industry, sector, region or other classification(s). A stock's coverage cluster is included in the most recent BofA M
accuracy or completeness.
t guarantee future results. Investment return and principal value will fluctuate so that shares, when sold, may be worth more or less than the

$11.26 billion defines the size (Large Cap or Small/Mid Cap) classification for domestic equity securities. The style (Growth or Value) for the
enner & Smith Incorporated ("MLPF&S") and/or one or more of its non-U.S. affiliates. MLPF&S is a wholly-owned subsidiary of Bank of Ame
onsibility or liability with respect to third-party research made available. Clients should understand that they assume full responsibility for an

(MLPF&S), and consists of the Merrill Edge Advisory Center (investment guidance) and self-directed online investing.

s Coverage Cluster (defined below). There are three investment ratings:

ed in the most recent BofA Merrill Lynch Global Research comment referencing the stock.
worth more or less than their original cost.

yle (Growth or Value) for these securities is defined by a proprietary procedure, which utilizes a series of quantitative and qualitative metrics
d subsidiary of Bank of America Corporation.
ume full responsibility for any trading decisions they make based upon third-party ratings or reports.

ve and qualitative metrics (e.g. expected earnings growth, analyst coverage, etc.)